Literature DB >> 33236845

Negative pressure wound therapy for burn patients: A meta-analysis and systematic review.

Dai-Zhu Lin1, Yu-Chien Kao1, Chiehfeng Chen2,3,4, Hsian-Jenn Wang2, Wen-Kuan Chiu2,5.   

Abstract

Negative pressure wound therapy (NPWT), which has been applied in various medical specialties to accelerate wound healing, has been the object of a few investigations. We explored the effectiveness of NPWT and the possibility of its inclusion in burn management guidelines. Randomised controlled trials comparing NPWT with non-NPWT treatments for burn wounds were extracted from PubMed. For the risk of bias analysis, all included studies were evaluated according to the Cochrane risk of bias tool and the approaches outlined in the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) Handbook. Outcomes such as graft take rate in the first week, infection rate, and overall complication rate were analysed. Six studies that included a total of 701 patients met our inclusion criteria. Qualitative analysis revealed that the NPWT group had a significantly better overall graft rate in the first week (P = 0.001) and a significantly lower infection rate (P = 0.04). No significant difference in the overall complication rate was found. Our results indicate that NPWT is a safe method for stimulating healing and lowering the infection rate of burn wounds. NPWT can be part of general burn management, and its incorporation into burn treatment guidelines is recommended.
© 2020 The Authors. International Wound Journal published by Medicalhelplines.com Inc (3M) and John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2020        PMID: 33236845      PMCID: PMC7949461          DOI: 10.1111/iwj.13500

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


INTRODUCTION

Burns is one of the leading causes of loss in terms of disability‐adjusted life years and accounts for an estimated 180 000 deaths annually in lower‐ and middle‐income countries. Burn survivors may experience lifelong physical and emotional complications that place a heavy financial burden on society. Although burn wounds have various classifications, the basics of wound healing and care are the same. The depth to which a burn has injured tissue determines the healing potential and the need for surgical grafting. Deep partial‐thickness burns take more than 3 weeks to heal even if no infection occurs. Delayed wound closure triggers scar formation and contracture, which can be prevented if excision and grafting are performed within the first few days of an injury. Various methods have been applied to optimise skin graft take, and much pioneering work has focused on improving grafting outcomes. , , Surgical interventions using split‐ and full‐thickness skin grafting has proven effective for burn wounds and were reported in the literature as early as 1817. Negative pressure wound therapy (NPWT), a non‐invasive therapy that uses negative pressure in a closed system, can be applied to wounds of diverse aetiology to promote healing. The use of negative pressure in wound treatment dates back to the Roman era; Roman soldiers were each assigned an individual to perform oral suctioning of wounds. NPWT began gaining popularity in 1997, following the publication of two articles , on the use of vacuum‐assisted closure. NPWT is now applied in many surgical specialties. Because it has been shown to accelerate both acute and chronic wound healing and reduce the length of hospital stay, NPWT is a popular method for treating soft‐tissue defects. , NPWT creates a moist healing environment while decreasing tissue oedema, promotes blood flow to the wound, increases granulation tissue formation, and stimulates angiogenesis, thereby reducing wound surface area. Although the mechanism by which NPWT promotes wound healing is not fully understood, some researchers believe that NPWT may contribute to removing inflammatory exudate from the donor site and reduce exposure to pathogens. In addition, Chen et al noted that wound stiffness during healing may positively affect cell migration, in which NPWT plays an important role, thereby accelerating wound healing. To the best of our knowledge, only one series of reviews has evaluated the effectiveness of NPWT for burn wounds in adults, and no meta‐analysis has been conducted on the topic; due to the limited number of completed randomised controlled trials (RCTs), conclusions regarding the treatment's merits have not been drawn. , In recent years, with NPWT's growing popularity and increased clinical use, more RCTs studying the correlation between its effectiveness in burn wound healing and graft take have been published. To evaluate the possibility of including NPWT in burn management guidelines, we conducted this systematic review. Our objectives were 3‐fold: first, to conduct a systematic review of the available evidence for the use of NPWT; second, to assess the quality of the available evidence; and third, to conduct a meta‐analysis to quantify the effectiveness of NPWT for improving burn wound healing.

MATERIALS AND METHODS

This study, comprising a systematic review and meta‐analysis, was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) statement.

Search strategy

Two reviewers (DZL and YCK) independently performed a systematic search of the PubMed database to identify relevant studies published from the inception of the database until May 16, 2020, using the following keywords: “NPWT” OR “negative pressure” AND “burn.” Only results in English and Chinese were included.

Selection criteria

Two reviewers (DZL and YCK) systematically and independently performed the initial search, removed duplicate records, screened the titles and abstracts for relevance, and classified studies as included, excluded, or uncertain. Any disagreements regarding inclusion or exclusion were resolved by a third investigator (CC). RCT inclusion was based on the following criteria: (a) the included population was patients with burn wounds, (b) the applied intervention was NPWT, (c) NPWT was compared with other therapies for burn wounds, and (d) at least one quantitative outcome was reported. Studies that were not in English or Chinese, used non‐human experimental groups or evaluated unrelated outcomes were excluded. Case reports, case series, and retrospective data analyses were also excluded.

Data extraction

Data extraction was performed independently by two reviewers (DZL and YCK) and checked by a third investigator (CC). Any disagreements regarding the collected data were resolved through discussion. The following data were extracted: patient demographic details, including the degree of the burn wound and mean total body surface area (TBSA; Table 1), and data related to outcomes, including graft take rate and complication rates (Table 2).
TABLE 1

Characteristics of trials included in the systematic review

TABLE 2

Outcomes of trials included in the systematic review

Authors/CountryGraft Take RateInfection RateOverall Complication RateMajor Complications
Bloemen et al (2012)/The Netherlands 22 Day 5None of the wounds were infected, pre‐ or postoperativelyPatients with complications (n, %)1. Contaminated wounds pre‐/post‐op:
(1) DS‐TNP = 94.8%(1) DS‐TNP = 7 (33)(1) DS‐TNP = 10/21 (48%)/10/14 (71%)
(2) DS = 92.4%(2) DS = 7 (30)(2) TNP = 5/21 (24%)/6/17 (35%)
(3) TNP = 94.2%(3) TNP = 5 (23)(3) DS = 10/22 (45%)/13/17 (76%)
(4) ST = 96.1%(4) ST = 2 (10)(4) ST = 8/18 (44%)/7/9 (78%)
2. Patients re‐op (n, %):
(1) DS‐TNP = 2 (10), (2) TNP = 1 (5), (3) DS = 3 (13), (4) ST = 1 (5)
3. Hematoma and graft loss: (1) DS‐TNP = 1, (2) TNP = 0, (3) DS = 2, (4) ST = 0
4. Graft shift: (1) DS‐TNP = 2, (2) TNP = 2, (3) DS = 0, (4) ST = 0
5. Graft loss (5%‐100%) (1) DS‐TNP = 2, (2) TNP = 3, (3) DS = 5, (4) ST = 2
6. Postop bleeding: (1) DS‐TNP = 1, (2) TNP = 0, (3) DS = 0, (4) ST = 0
Hsiao et al (2016)/Taiwan 23

Week 1

NPWT: 71.4%

control: 85.7%

No wound infection was noted in any patients

Itching (%)

NPWT: 0

control: 7.1

No unwanted event (such as seroma formation) and no formation of hypertrophic scar
Ibrahim et al (2019)/Egypt 24

Wound surface area Percentage change ± SD (%)

NPWT/MES/control

(1) Pre‐treatment—Day 10: 27.8 ± 6.6/47.2 ± 7.2/15.7 ± 5.7

(2) Pre‐treatment—Day 21: 74.7 ± 16.4/85.4 ± 10.6/37.2 ± 10.4

Liu et al (2016)/China 25

Day 7/14/21 (%)

NPWT: 40.6 ± 1.0/60.9 ± 1.5/90.6 ± 5.1

NPWT + ADM: 39.8 ± 1.2/77.1 ± 2.3/98.7 ± 1.7

ADM: 10.6 ± 0.3/55.9 ± 1.4/75.0 ± 1.8

Infected wounds/total wounds at day 21

NPW: 2/18 (0.11%)

NPWT+ADM: 2/23 (0.08%)

ADM: 8/11 (0.72%)

Infected wounds/total wounds at day 21

NPW: 2/18 (0.11%)

NPWT+ADM: 2/23 (0.08%)

ADM: 8/11 (0.72%)

Petkar et al (2011)/India 26

Day 9 Percentage ± SD

NPWT: 96.67% ± 3.554

control: 87.53% ± 8.733

1. Air leak: 5 in NPWT group
2. Post‐operative day when dressing was discontinued for self‐massage with moisturiser was noted
3. No serious adverse effects in either group
Wen et al (2017)/China 27

Number/total

NPWT: 6/225 (2.67%)

control: 10/225 (4.44%)

Number/total

NPWT: 18/225 (8%)

control: 32/225 (14.22%)

Abbreviations: ADM, acellular dermal matrix; DS, dermal substitute; MES, microcurrent electrical stimulation; NPWT, negative pressure wound therapy; ST, standard treatment; STSG, split‐thickness skin graft; TNP, topical negative pressure.

Characteristics of trials included in the systematic review Outcomes of trials included in the systematic review Week 1 NPWT: 71.4% control: 85.7% Itching (%) NPWT: 0 control: 7.1 Wound surface area Percentage change ± SD (%) NPWT/MES/control (1) Pre‐treatment—Day 10: 27.8 ± 6.6/47.2 ± 7.2/15.7 ± 5.7 (2) Pre‐treatment—Day 21: 74.7 ± 16.4/85.4 ± 10.6/37.2 ± 10.4 Day 7/14/21 (%) NPWT: 40.6 ± 1.0/60.9 ± 1.5/90.6 ± 5.1 NPWT + ADM: 39.8 ± 1.2/77.1 ± 2.3/98.7 ± 1.7 ADM: 10.6 ± 0.3/55.9 ± 1.4/75.0 ± 1.8 Infected wounds/total wounds at day 21 NPW: 2/18 (0.11%) NPWT+ADM: 2/23 (0.08%) ADM: 8/11 (0.72%) Infected wounds/total wounds at day 21 NPW: 2/18 (0.11%) NPWT+ADM: 2/23 (0.08%) ADM: 8/11 (0.72%) Day 9 Percentage ± SD NPWT: 96.67% ± 3.554 control: 87.53% ± 8.733 Number/total NPWT: 6/225 (2.67%) control: 10/225 (4.44%) Number/total NPWT: 18/225 (8%) control: 32/225 (14.22%) Abbreviations: ADM, acellular dermal matrix; DS, dermal substitute; MES, microcurrent electrical stimulation; NPWT, negative pressure wound therapy; ST, standard treatment; STSG, split‐thickness skin graft; TNP, topical negative pressure.

Statistical analysis

The analysis was performed using Review Manager (RevMan Version 5.4; Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014). Categorical variables were reported as odds ratios (OR) and 95% confidence intervals (CIs). Data heterogeneity was assessed using the I 2 index. Statistical significance was set at P < 0.05. ,

Quality assessment

Two reviewers (DZL and YCK) independently assessed the studies' potential risk of bias after data collection. The Cochrane risk of bias tool was used to assess the possibility of bias, which includes six domains for RCTs: (a) random sequence generation, (b) allocation concealment, (c) blinding of participants and personnel, (d) blinding of outcome assessment, (e) incomplete outcome data, and (f) selective reporting. The reviewers ranked each category for each study as having a low, high, or plausible risk of bias. For the overall risk of bias, any differences between the assessments of the two reviewers were resolved by a third investigator (CC). We applied the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach for rating the quality of evidence for each comparison, and we used GRADEpro GDT to summarise the GRADE results in a table.

RESULTS

Six RCTs that included a total of 701 patients were selected for review. Data extracted from these studies formed the basis of this systematic review. , , , , , The flowchart of the literature search is provided in Figure 1.
FIGURE 1

Flow chart of the study selection

Flow chart of the study selection

Characteristics of included studies

The included studies were published between 2011 and 2019 and investigated varying degrees and TBSA of burn wounds. Follow‐up time ranged from 3 days preoperation to 3 months postoperation. Among the studies, several types of NPWT interventions were used. Two studies applied the intermittent mode of NPWT, , in which negative pressure is repeatedly switched on and off over a period of 24 hours. In the remainder , , , of cases, negative pressure was maintained for three to 7 days. Regarding the magnitude of the pressure, three of the studies applied pressure of −125 mmHg, , , whereas Petkar et al and Wen, respectively, used −80 mmHg and −9.30 kPa (approximately −70 mmHg). Moreover, the studies used different combinations of NPWT and control groups. Three studies compared the application of NPWT with a split‐thickness skin graft (STSG) with the use of STSG alone. , , One study evaluated STSG with or without NPWT and with or without a dermal substitute (DS) with the combined use of STSG and DS. Two studies compared the combined application of NPWT and porcine acellular dermal matrix (ADM) with the use of ADM alone or conventional dressing. One study compared the application of NPWT with the use of ADM.

Effects of interventions

Graft take rate in the first week

Five studies reported graft take rate in the first week, , , , , of which four provided assessable data , , , that were analysed for experimental and control groups (Figure 2).
FIGURE 2

Forest plot and meta‐analysis showing the standard mean difference of graft take rate at week one between NPWT (negative pressure wound treatment) and control groups

Forest plot and meta‐analysis showing the standard mean difference of graft take rate at week one between NPWT (negative pressure wound treatment) and control groups The pooled analysis indicated an overall significantly improved graft take rate in the first week in the NPWT groups compared with control groups (standardised mean difference [SMD]: 2.62 [95% CI: 1.01, 4.22]; I 2: 94%, P = 0.001; Figure 2). Improved graft take rate at first week was noted in the following three subgroups: (a) NPWT and DS compared with DS (SMD: 5.93 [95% CI: 4.27, 7.60]; P < 0.0001; Figure 2.1.3), (b) NPWT compared with DS (SMD: 8.52 [95% CI: 6.05, 11.00]; P < 0.00001; Figure 2.1.4), and (c) NPWT to conventional dressing therapy alone (SMD: 1.91 [95% CI: 1.03, 2.79]; P < 0.00001; Figure 2.1.5). No significant difference in graft take rate at first week was observed between the experimental (NPWT, DS, and STSG) groups and the control (DS and STSG) groups (SMD: 0.2 [95% CI: −0.40, 0.79]; P = 0.65; Figure 2.1.1). No significant difference was found between the NPWT and STSG experimental groups and the control groups using STSG alone (SMD: 0.63 [95% CI: −0.86, 2.13]; I 2: 86%, P = 0.41; Figure 2.1.2).

Complication rates

Complication rates, including infection rate and overall complication rate, are shown in Figure 3. The infection rate was reported in two studies. , The pooled analysis showed significantly lower odds compared with control groups (OR: 0.12 [95% CI: 0.02, 0.87]; I 2: 78%, P = 0.04; Figure 3.1.1). Bloemen et al and Hsiao et al observed a 0% infection rate across the experimental and control groups. The overall complication rate, which four studies reported, , , , showed no significant reduction of odds in the NPWT groups in the pooled analysis (OR: 0.59 [95% CI: 0.16, 2.17]; I 2: 78%, P = 0.42; Figure 3.1.2). Petkar et al reported no serious adverse effects in either group.
FIGURE 3

Forest plot and meta‐analysis showing mean difference of complication rate between NPWT (negative pressure wound treatment) and control groups

Forest plot and meta‐analysis showing mean difference of complication rate between NPWT (negative pressure wound treatment) and control groups

DISCUSSION

This systematic review and meta‐analysis study summarised the available evidence on the effects associated with the application of NPWT for burn wounds. Overall, the NPWT groups demonstrated more improvement in graft take rate in the first week and a lower infection rate compared with the other groups. Between‐group differences in overall complication rates were not significant.

Graft take rate

The overall graft take rate was significantly improved in the first week in the NPWT groups compared to the control groups. NPWT has better graft take comparing with dressing alone. No significant difference was found between the STSG group using NPWT and the group using STSG alone. Nevertheless, some reviews and meta‐analyses comparing the use of NPWT versus other therapies on STSG have demonstrated that NPWT can improve graft take. , , , Therefore, NPWT may still have potential benefits for skin grafting of burn wounds. Blood filling of autochthonous graft capillaries usually occurs on day three. Through interconnections between the wound bed and skin grafts, skin microcirculation is almost completely restored by day five. This may further explain our overall positive graft take rates in the first week. The removal of excess exudate through NPWT reduces the risk of hematoma formation and prevents the complications of graft shear or lift‐off , , ; this is consistent with our graft take results. In our study, two RCTs included DS as an adjunct to burn wound treatment. , However, the different interventions between the control groups preclude us from drawing any statistical conclusions. A limited benefit on graft take has been reported for the use of DS in burns. , , DS was demonstrated to reduce and delay graft take due to vascular ingrowth on the DS surface; it can be improved through NPWT application, as reported by Bloemen et al (an included study). NPWT can improve revascularisation through the induction of collagen transcription and angiogenesis, adhere to DS to the wound bed, and eventually improve skin graft take. , The benefits of applying NPWT to DS remain unclear, and larger trials are required before a conclusion can be reached. In conclusion, it showed that among the overall significant better graft take in NPWT groups, first, it is better than conventional dressing therapy alone. Second, for the effects combining with DS or STSG, NPWT provides a better condition for DS to adhere, but little improvement with STSG in our study.

Complications

Our infection rate outcomes indicated a significant risk reduction, which is consistent with findings from several past reviews. , , , , , , It is suggested that NPWT decreases the infection rate due to the following reasons: For wound care management, the NPWT systems lower dressing frequency, the wound site would be exposed less. , , For a wound healing environment, NPWT could provide a positive wound environment by removing the healing inhibitors such as metalloproteinases in the wound exudate and clear microorganisms, , promote better microvascular circulation to lower the bacterial colonisation. , , However, others have found equivocal evidence. , , The controversy may be due to the variation in patient inclusion and exclusion criteria and in methodology. In our study, between‐group differences in overall complication rates were not significant, but the rate in NPWT patients was improved. The studies we assessed reported various complications related to NPWT, leading to an inaccurate assessment. Nevertheless, their findings suggest that in general, patients receiving NPWT experienced improved wound healing with less discomfort.

Burn guidelines and contraindications to NPWT

According to the World Health Organisation, full‐thickness burns in the healing phase should undergo skin grafting after wound excision. Regardless of this recommendation, NPWT remains excluded from current guidelines on burn wound treatment. We believe that NPWT has the potential to become standard for burn wound treatment. Generally, NPWT is considered highly safe ; its most serious complication other than infection is bleeding. However, to prevent haemorrhage from the affected vessels, NPWT is contraindicated for patients with arterial erosion, active massive haemorrhage, and necrosis. , Several of our included studies noted its contraindications for other groups, including patients with coagulopathy, , , , because untreated coagulopathy can cause bleeding and infection during NPWT. However, NPWT is not contraindicated for patients receiving anticoagulant or platelet aggregation inhibitor therapy, provided its use is strictly monitored. , , We believe that NPWT is beneficial in the majority of patients with burn wounds.

Pressure settings for NPWT

The pressure settings in the included studies ranged from −70 to −125 mmHg, with three studies using −125 mmHg in their experimental groups. , , We found that most studies on NPWT have used an optimal pressure of −125 mmHg. In an early study done on pigs, peak blood flow was −125 mmHg, which was four times higher than the baseline. By contrast, another study on pigs observed a maximal net increase of blood flow in muscular tissue between −75 and − 100 mmHg. The difference in optimal pressure setting can be explained by differences in wound sites and tissue components. The same researchers concluded in another study that for subcutaneous and muscular wounds, the optimal pressure is −75 and − 100 mmHg, respectively. One study recommended adjusting the pressure from −70 to −125 mmHg after 72 hours of treatment and routinely placing paraffin gauze over the tissue to reduce adhesion and minimise trauma. While further research on the optimal pressure settings of NPWT necessary for maximal wound healing is warranted, −125 mmHg is widely accepted pressure for NPWT so far. Two studies included in our review used the intermittent mode of NPWT. , Studies comparing the differences between modes of NPWT are limited. Two studies have concluded that more granulation tissue may be formed in the non‐continuous mode (intermittent or variable pressure modes) than in the continuous mode. , By contrast, a study by Lessing et al found no significant difference between continuous and non‐continuous NPWT in any of the outcomes. A recent study evaluating the clinical benefits of intermittent NPWT showed that it can improve local perfusion and oxygen supply to the wound. Taking all the evidence into account, which NPWT mode should be used for optimal healing outcomes remains unclear. In summary, the settings of NPWT are most appropriated and most commonly used at −125 mmHg for both intermittent and continuous mode to date. Table 1 illustrates the quality assessment results, which indicate several potential biases in some of the included studies. The Cochrane risk of bias tool was applied to RCTs, and with respect to allocation concealment, one study had low risk, the risk was unclear in one, and the remaining had high risk. , , , Because blinding of participants and personnel is inapplicable to NPWT, none of the studies were considered to be at low risk for it. Likewise, blinding of outcome assessment is inapplicable to NPWT; only one study was at low risk of this. These concerns might have led to subjective judgement bias. Based on the GRADE assessment (Table 3), the evidence assessed in graft take rate in the first week is of high certainty, evidence for infection rate (downgraded once for high risk of bias and once for inconsistency) is of low certainty, and evidence for the overall complication rate (downgraded once for high risk of bias and once for inconsistency) is of low certainty. According to the forward assessment, incorporating NPWT into burn management guidelines is worth considering.
TABLE 3

ÐRADE (grading of recommendations, assessment, development, and evaluation) assessment of the meta‐analysis

Certainty AssessmentNo of PatientsEffectCertaintyImportance
No of StudiesStudy DesignRisk of BiasInconsistencyIndirectnessImprecisionOther ConsiderationsNPWTConventional TreatmentRelative (95% CI)Absolute (95% CI)
Graft take rate at week 1
4Randomised trialsNot seriousNot seriousNot seriousNot seriousNone12085SMD 2.62 higher (1.01 higher to 4.22 higher)⊕⊕⊕⊕ HIGHCRITICAL
Complication rate – Infection rate
2Randomised trialsSerious a Serious b , c Not seriousNot seriousNone10/266 (3.8%)26/247 (10.5%)OR 0.12 (0.02‐0.87)91 fewer per 1000 (from 103 fewer to 12 fewer)⊕⊕○○ LOWCRITICAL
Complication rate – overall complication rate
4Randomised trialsSerious d Serious b , e Not seriousNot seriousNone41/346 (11.8%)55/321 (17.1%)OR 0.59 (0.16‐2.17)63 fewer per 1000 (from 139 fewer to 138 more)⊕⊕○○ LOWCRITICAL

Abbreviations: CI, confidence interval; OR, odds ratio; SMD, standardised mean difference.

High risk of bias due to lack of blinding. None of them were able to blind the participants and personnel. Both RCTs' outcome assessors were not blinded for any outcomes.

The variability is substantial, but differences are between small and large beneficial effects.

Heterogeneity P = 0.01, I ^ 2 = 78%.

High risk of bias due to a lack of blinding. None of them were able to blind the participants and personnel. 1 RCT's outcome assessors were not blinded for any outcomes while 3 RCTs were unclear on it.

Heterogeneity P = 0.0001, I ^ 2=78%.

ÐRADE (grading of recommendations, assessment, development, and evaluation) assessment of the meta‐analysis Abbreviations: CI, confidence interval; OR, odds ratio; SMD, standardised mean difference. High risk of bias due to lack of blinding. None of them were able to blind the participants and personnel. Both RCTs' outcome assessors were not blinded for any outcomes. The variability is substantial, but differences are between small and large beneficial effects. Heterogeneity P = 0.01, I ^ 2 = 78%. High risk of bias due to a lack of blinding. None of them were able to blind the participants and personnel. 1 RCT's outcome assessors were not blinded for any outcomes while 3 RCTs were unclear on it. Heterogeneity P = 0.0001, I ^ 2=78%.

LIMITATIONS

This study has several limitations. First, the comparison variation was high, possibly contributing to the finding of varying degrees of effectiveness for NPWT. Second, the variation in application methods and duration of NPWT could have affected the outcomes. The limited number of RCTs and their relatively small sample sizes may also be considered limitations.

CONCLUSIONS

NPWT is a safe method for accelerating healing and lowering the infection rate of burn wounds. Its use in burn wound treatment is recommended provided it is applied under appropriate circumstances. However, the optimal pressure settings of NPWT warrant further investigation, and further large‐scale RCTs are required to provide more evidence of its effectiveness for treating burn wounds.
  54 in total

Review 1.  The History of Negative Pressure Wound Therapy (NPWT): From "Lip Service" to the Modern Vacuum System.

Authors:  Christine Miller
Journal:  J Am Coll Clin Wound Spec       Date:  2013-11-28

2.  Blood flow responses in the peristernal thoracic wall during vacuum-assisted closure therapy.

Authors:  Angelica Wackenfors; Ronny Gustafsson; Johan Sjögren; Lars Algotsson; Richard Ingemansson; Malin Malmsjö
Journal:  Ann Thorac Surg       Date:  2005-05       Impact factor: 4.330

Review 3.  Fix and flap in the era of vacuum suction devices: What do we know in terms of evidence based medicine?

Authors:  James P Stannard; Naveen Singanamala; David A Volgas
Journal:  Injury       Date:  2010-05-14       Impact factor: 2.586

Review 4.  Current concepts in negative pressure wound therapy.

Authors:  Lisa M Howe
Journal:  Vet Clin North Am Small Anim Pract       Date:  2015-03-03       Impact factor: 2.093

Review 5.  Effect of negative pressure wound therapy on wound healing.

Authors:  Chenyu Huang; Tripp Leavitt; Lauren R Bayer; Dennis P Orgill
Journal:  Curr Probl Surg       Date:  2014-04-26       Impact factor: 1.909

6.  Occlusive drainage system for split-thickness skin graft: A prospective randomized controlled trial.

Authors:  Sara Fu-Yin Hsiao; Hsu Ma; Yu-Hei Wang; Tien-Hsiang Wang
Journal:  Burns       Date:  2016-10-27       Impact factor: 2.744

Review 7.  Negative Pressure Wound Therapy for Burns.

Authors:  Neel A Kantak; Riyam Mistry; David E Varon; Eric G Halvorson
Journal:  Clin Plast Surg       Date:  2017-04-07       Impact factor: 2.017

8.  The effects of variable, intermittent, and continuous negative pressure wound therapy, using foam or gauze, on wound contraction, granulation tissue formation, and ingrowth into the wound filler.

Authors:  Malin Malmsjö; Lotta Gustafsson; Sandra Lindstedt; Bodil Gesslein; Richard Ingemansson
Journal:  Eplasty       Date:  2012-01-24

9.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18

Review 10.  Meta-analysis of negative-pressure wound therapy for closed surgical incisions.

Authors:  N Hyldig; H Birke-Sorensen; M Kruse; C Vinter; J S Joergensen; J A Sorensen; O Mogensen; R F Lamont; C Bille
Journal:  Br J Surg       Date:  2016-04       Impact factor: 6.939

View more
  4 in total

Review 1.  Israeli Innovations in the Field of Plastic Surgery.

Authors:  Lior Har-Shai; Sar-El Ofek; Stav Cohen; Keren H Cohen; Dafna Shilo Yaacobi; Asaf Olshinka; Rami P Dibbs; Dean D Ad-El
Journal:  Semin Plast Surg       Date:  2022-05-26       Impact factor: 2.195

2.  Negative Pressure Wound Therapy After Abdominal Body Contouring: A Comparative Matched Analysis of Outcomes and Cost.

Authors:  Martin P Morris; Adrienne N Christopher; Viren Patel; Ginikanwa Onyekaba; Robyn B Broach; John P Fischer
Journal:  Plast Surg (Oakv)       Date:  2021-06-03       Impact factor: 0.558

3.  Negative pressure wound therapy for burn patients: A meta-analysis and systematic review.

Authors:  Dai-Zhu Lin; Yu-Chien Kao; Chiehfeng Chen; Hsian-Jenn Wang; Wen-Kuan Chiu
Journal:  Int Wound J       Date:  2020-11-25       Impact factor: 3.315

Review 4.  Review of History of Basic Principles of Burn Wound Management.

Authors:  Hyunjin Kim; Seongmee Shin; Donghoon Han
Journal:  Medicina (Kaunas)       Date:  2022-03-07       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.